Autolus Therapeutics Stock Forecast

Stock Price Forecast

According to 9 analysts polled by S&P Global, Autolus Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $8.55. The average 1-year stock price forecast is 441.14% higher than the current stock price, while the lowest is $5.00 (+216.46%) and the highest is $11 (+596.20%).

Price Target: $8.55 (+441.14%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$5.00	$8.55	$9.50	$11
Change	+216.46%	+441.14%	+501.27%	+596.20%

Analyst Ratings

The average analyst rating for Autolus Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	9	10	10	10	9	8
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	11	11	11	10	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Salim Syed Mizuho Securities	Mizuho Securities	Buy Maintains $10	Buy	Maintains	$10	+532.91%	Jun 10, 2026
Matt Phipps William Blair	William Blair	Buy Maintains n/a	Buy	Maintains	n/a	n/a	Jun 3, 2026
Unknown Analyst Wells Fargo No rating	Wells Fargo	Buy Reiterates $5	Buy	Reiterates	$5	+216.46%	May 15, 2026
Unknown Analyst Goldman Sachs No rating	Goldman Sachs	Buy Reiterates $6.1 → $5.4	Buy	Reiterates	$6.1 → $5.4	+241.77%	May 15, 2026
Gil Blum Needham	Needham	Buy Maintains $10	Buy	Maintains	$10	+532.91%	May 14, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

128.57M

from 75.39M

70.55%

from 75.39M

Revenue Next Year

190.98M

from 128.57M

48.54%

from 128.57M

EPS This Year

-0.88

from -1.08

EPS Next Year

-0.60

from -0.88

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	2.33M	6.36M	1.70M	10.12M	75.39M	128.57M
Revenue Growth	35.86%	172.96%	-73.30%	496.00%	644.94%	70.55%
Operating Income	-140.37M	-142.89M	-175.53M	-241.01M	-270.20M	-225.26M
Net Income	-142.10M	-148.84M	-208.38M	-220.66M	-287.53M	-241.54M
EPS	-	-	-	-	-1.08	-0.88
Free Cash Flow	-77.76M	-75.76M	-125.13M	-206.33M	-249.40M	-173.15M
No. Analysts	-	-	-	-	-	8

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	146.5M
Avg	128.6M
Low	121.7M

Revenue Growth

Revenue Growth	2026	2027	2028
High	94.3%
Avg	70.5%
Low	61.4%

EPS Forecast

EPS	2026	2027	2028
High	-0.56
Avg	-0.88
Low	-1.24

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-